2019 IPO

Kaleido BioSciences Stock

Kaleido BioSciences is a company working to design and analyze the microbiome system and provide adaptive solutions.

Sign up today and learn more about Kaleido BioSciences Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Kaleido BioSciences Stock

Tremendous new therapeutic opportunities are emerging from our rapidly expanding knowledge of the human microbiome. Kaleido is exploring this newfound territory through a unique discovery platform that develops novel chemistries targeted at specific microbiome functions. Our approach has produced clinically supported leads in multiple disease areas.

Funding History

August 2015$4.5M
September 2017$60.0M
June 2018$101M


EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: